LEPR Gln223Arg GA genotype was represented in 40% of controls, 70% of chronic hepatitis C patients, 40% of NASH patients, 80% of cirrhotic patients and 35% of HCC patients. The gene discussed is LEPR; the disease is chronic hepatitis C virus infection.